Evidence map›Paper›PMID 42265118›Full record

ArticleNature communications2026

Neutral chiral bidentate tellurium-triazoles for enantioselective non-covalent chalcogen-bonding catalysis.

Lary Massold, James O'Brien, Kevin Fengler, Alica C Keuper, Raquel Hidalgo-León, Cristina Trujillo, Olga García Mancheño

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lary Massold *Leibniz Institute for Catalysis, Albert-Einstein-Straße 29A, Rostock, Germany.
James O'Brien *Department of Chemistry, The University of Manchester, Oxford Road, Manchester, UK.
Kevin FenglerInstitute of Organic Chemistry, University of Münster, Corrensstraße 36, Münster, Germany.
Alica C KeuperInstitute of Organic Chemistry, University of Münster, Corrensstraße 36, Münster, Germany.
Raquel Hidalgo-LeónInstitute of Organic Chemistry, University of Münster, Corrensstraße 36, Münster, Germany.
Cristina TrujilloDepartment of Chemistry, The University of Manchester, Oxford Road, Manchester, UK. cristina.trujillodelvalle@manchester.ac.uk.ORCID http://orcid.org/0000-0001-9178-5146
Olga García MancheñoLeibniz Institute for Catalysis, Albert-Einstein-Straße 29A, Rostock, Germany. olga.garcia@catalysis.de.ORCID http://orcid.org/0000-0002-7578-5418

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chalcogen-bonding (ChB) has recently garnered significant interest in the field of non-covalent catalysis, providing new possibilities through σ-hole interactions. However, the advancement of the field in enantioselective catalysis relying purely on ChB has been impeded by the inherent directionality of the interaction and presence of several σ-holes on the chalcogen atom, being particularly challenging with neutral ChB-donors. Herein, we report the design and application of chiral ChB-donors able to accomplish the still challenging asymmetric chalcogen-bonding catalysis with neutral ChB systems, reaching enantioselectivities of up to 11:89 e.r. in the anion-binding benchmark Reissert-type reaction of (iso)quinolines. Optimization of the chiral central backbone in rather simple bistriazole-bistelluride-based structures to accomplish a bidentate binding to Lewis basic substrates is performed, leading to the identification of the (R,R)-1,3-diamino cyclohexane moiety as appropriate chiral spacer. While no binding is observed for other chiral central backbones, a moderate affinity to chloride anion as model substrate is recorded for the optimized neutral ChB-donor, for which key binding features are further revealed upon computational analysis on the corresponding catalyst-chloride complex.

Identifiers

PMID42265118
PMCPMC13402837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.